ALXO Stock Analysis: Buy, Sell, or Hold?

ALXO - ALX Oncology Holdings Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$1.74
0.17 (10.83%) ▲
WAIT
LOW Confidence
Protect Your ALXO Gains
Last Updated: January 30, 2026
Earnings: Mar 05, 2026

Get Alerted When ALXO Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ALXO is 16.0% above fair value ($1.50). While momentum could continue, risk/reward favors waiting for a pullback.

In-depth Analysis How we analyze

Valuation Analysis: ALXO is currently trading at $1.74, which is considered extended relative to its 30-day fair value range of $1.19 to $1.50.

Technical Outlook: Technically, ALXO is in a strong uptrend. Immediate support is located at $1.16, while resistance sits at $1.93. The stock is showing strong short-term momentum, up 10.8% recently.

Market Sentiment: ALXO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.00 (+91.1%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Fair Price Range $1.19 - $1.50
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.9%

Protect Your Profits

Holding ALXO? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Price significantly overextended (+16.0% above fair value)
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+10.8%)
  • BULLISH: Trading 91.1% below Wall St target ($3.00)
  • WARNING: Recommendation downgraded due to 16.0% overvaluation

Fair Price Analysis

30-Day Fair Range $1.19 - $1.50
Current vs Fair Value EXTENDED

Support & Resistance Levels

Support Level $1.16
Resistance Level $1.93
Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) -2.09
Wall Street Target $3.00 (+91.1%)
Revenue Growth (YoY) -100.0%
Last updated: January 30, 2026 4:03 PM ET
Data refreshes hourly during market hours. Next update: 5:03 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Jason Lettmann BUY 71163 shares 2025-09-17
Jason Lettmann BUY 21070 shares 2025-09-16

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$66 46 HOLD
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$112 52 HOLD
RNA
Avidity Biosciences Inc
STRONG BUY
15 analysts
$75 62 BUY
DNTH
Dianthus Therapeutics In…
STRONG BUY
12 analysts
$65 60 HOLD
TVTX
Travere Therapeutics Inc
STRONG BUY
15 analysts
$42 53 HOLD

Advanced ALXO Option Strategies

Professional options setups generated by AI based on today's ALXO price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ALXO

ALXO Technical Chart ALXO Price Prediction ALXO Earnings Date ALXO Investment Advisor ALXO Fair Price Analyzer ALXO Options Advisor ALXO Options Chain ALXO Options Analysis ALXO Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals